Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Sreedharan A, et al. Among authors: crellin a. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005048. doi: 10.1002/14651858.CD005048.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328271 Updated. Review.
Interventions for dysphagia in oesophageal cancer.
Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Sreedharan A, et al. Among authors: crellin a. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005048. doi: 10.1002/14651858.CD005048.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821338 Updated. Review.
Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma.
Ward G, Ramasamy S, Sykes JR, Prestwich R, Chowdhury F, Scarsbrook A, Murray P, Harris K, Crellin A, Hatfield P, Sebag-Montefiore D, Spezi E, Crosby T, Radhakrishna G. Ward G, et al. Among authors: crellin a. Clin Oncol (R Coll Radiol). 2016 Oct;28(10):655-62. doi: 10.1016/j.clon.2016.05.009. Epub 2016 Jun 3. Clin Oncol (R Coll Radiol). 2016. PMID: 27266819 Free article.
Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis.
Jones CM, Spencer K, Hitchen C, Pelly T, Wood B, Hatfield P, Crellin A, Sebag-Montefiore D, Goody R, Crosby T, Radhakrishna G. Jones CM, et al. Among authors: crellin a. Clin Oncol (R Coll Radiol). 2019 Jun;31(6):356-364. doi: 10.1016/j.clon.2019.01.010. Epub 2019 Feb 5. Clin Oncol (R Coll Radiol). 2019. PMID: 30737068 Free article.
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.
Alderson D, Cunningham D, Nankivell M, Blazeby JM, Griffin SM, Crellin A, Grabsch HI, Langer R, Pritchard S, Okines A, Krysztopik R, Coxon F, Thompson J, Falk S, Robb C, Stenning S, Langley RE. Alderson D, et al. Among authors: crellin a. Lancet Oncol. 2017 Sep;18(9):1249-1260. doi: 10.1016/S1470-2045(17)30447-3. Epub 2017 Aug 4. Lancet Oncol. 2017. PMID: 28784312 Free PMC article. Clinical Trial.
59 results